| 5.38 -0.52 (-8.81%) | 06-12 13:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 8.03 | 1-year : | 9.38 |
| Resists | First : | 6.87 | Second : | 8.03 |
| Pivot price | 5.74  |
|||
| Supports | First : | 4.35 |
Second : | 2.79 |
| MAs | MA(5) : | 5.97 |
MA(20) : | 5.3 |
| MA(100) : | 3.11 |
MA(250) : | 3.02 |
|
| MACD | MACD : | 0.7 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 62 |
D(3) : | 70.2 |
| RSI | RSI(14): 58.7 |
|||
| 52-week | High : | 6.87 | Low : | 1.08 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ GRDX ] has closed above bottom band by 44.4%. Bollinger Bands are 86% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 20 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.09 - 6.12 | 6.12 - 6.14 |
| Low: | 5.63 - 5.66 | 5.66 - 5.69 |
| Close: | 5.85 - 5.9 | 5.9 - 5.95 |
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Sun, 07 Jun 2026
Number of shareholders of GridAI Technologies Corp. – NASDAQ:GRDX - TradingView
Thu, 04 Jun 2026
1.31M shares tied to warrants registered for resale by GridAI (NASDAQ: GRDX) - Stock Titan
Wed, 03 Jun 2026
GridAI Technologies Corp. (GRDX) director receives 40,000 restricted stock units - Stock Titan
Wed, 27 May 2026
GridAI Technologies Corp. announced that it has received $5.249995 million in funding - marketscreener.com
Wed, 27 May 2026
GridAI Technologies Corp. 1Q 2026: Revenue $38K, EPS ($0.82) — 10-Q Summary - TradingView
Wed, 29 Apr 2026
GridAI heads to 48 Wall Street for a May 5 investor summit talk - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 7 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 8.5 (%) |
| Held by Institutions | 5.2 (%) |
| Shares Short | 58 (K) |
| Shares Short P.Month | 55 (K) |
| EPS | -4.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1.36 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|